The Children’s Oncology Group (COG) is conducting important maintenance on COG systems on Sunday, February 21st between 9am and 2pm (PST). All COG systems and services will be unavailable during this time period. This includes, but is not limited to: patient registration, enrollment, callback, manual treatment assignment and study data entry in eRDES/OPEN/RDE1 systems (data entry in iMedidata, Rave will not be affected), all COG Web and desktop applications and the BPC Kit Management Web application.
The Children’s Oncology Group provides important information for children and their families from the time of diagnosis, through treatment and following cure. Our experts in childhood cancer are available throughout the United States, Canada and a number of international sites. Find a Children’s Oncology Group location near you and download our Family Handbook for more information.
Children’s Oncology Group’s Project:EveryChild is our ambitious initiative to find better cures for every type of childhood cancer, no matter how rare. All children with cancer cared for at COG’s more than 200 pediatric cancer programs will be able to participate in Project:EveryChild. Learn more about Project:EveryChild, including our Hyundai Hope On Wheels Biorepository™ and how you can help lead the way.
The Children’s Oncology Group is dedicated to improving the outcome for all children with cancer. Our global research team needs your help to turn today’s discoveries into tomorrow’s cures. With more than 90% of children with cancer cared for at COG sites, learn how you can help be part of the cure.
The Children’s Oncology Group partners with research scientists from around the world in our efforts to understand the causes of cancer and find more effective treatments for the children we care for. Learn how to become a member of the Children’s Oncology Group. You may also learn more about the COG Supportive Care Guidelines.
Partner with the Children’s Oncology Group from laboratory discovery to all phases of clinic trials. Our well-established clinical research infrastructure is dedicated to efficiently delivering results to help develop new treatments and provide the data necessary for filings with global regulatory agencies.
The Children’s Oncology Group (COG) is the most experienced organization in the world in clinical development of new therapeutics for children and adolescents with cancer. The COG Phase 1 & Pilot Consortium is a limited institution consortium, comprised of 21 premier pediatric oncology programs in the country.